NCT04311242View on ClinicalTrials.gov

Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

April 15, 2020

Primary Completion Date

February 23, 2021

Study Completion Date

February 23, 2021

Conditions
Epilepsy
Interventions
OTHER

Diet

Ketogenic diet

Trial Locations (1)

02116

Boston Children's Hospital, Boston

Sponsors

Lead Sponsor

Senda Biosciences
All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

lead

Senda Biosciences

INDUSTRY

NCT04311242 - Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy | Biotech Hunter | Biotech Hunter